AssetMark’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14 Hold
1
– – ﹤0.01% 3754
2026
Q2
$22 Hold
1
– – ﹤0.01% 3532
2026
Q1
$14 Hold
1
– – ﹤0.01% 3425
2025
Q4
$15 Hold
1
– – ﹤0.01% 3359
2025
Q3
$9 Hold
1
– – ﹤0.01% 3174
2025
Q2
$10 Buy
+1
New +$34 ﹤0.01% 2993

Other funds holding JBIO

AssetMark's JBIO Position: Q3 2026 in Review

AssetMark held its Jade Biosciences (JBIO) position steady in Q3 2026 at 1 share worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #3754.

AssetMark first reported a position in JBIO in Q2 2025 and has held it in 6 quarters since. The position peaked at $22 in Q2 2026. 102 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

  • AssetMark held 1 share of Jade Biosciences worth $14 as of Q3 2026.
  • AssetMark left its Jade Biosciences share count unchanged in Q3 2026.
  • Jade Biosciences made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3754 holding.
  • AssetMark first reported a position in Jade Biosciences in Q2 2025 and has held it in 6 quarters since.
  • AssetMark's Jade Biosciences position peaked at $22 in Q2 2026.
  • 102 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.